173 related articles for article (PubMed ID: 11595659)
1. Mechanisms of insulin resistance in cystic fibrosis.
Hardin DS; Leblanc A; Marshall G; Seilheimer DK
Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E1022-8. PubMed ID: 11595659
[TBL] [Abstract][Full Text] [Related]
2. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance is associated with decreased clinical status in cystic fibrosis.
Hardin DS; LeBlanc A; Lukenbough S; Seilheimer DK
J Pediatr; 1997 Jun; 130(6):948-56. PubMed ID: 9202618
[TBL] [Abstract][Full Text] [Related]
4. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis.
Hardin DS; LeBlanc A; Para L; Seilheimer DK
Diabetes; 1999 May; 48(5):1082-7. PubMed ID: 10331413
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
Bitar MS; Al-Saleh E; Al-Mulla F
Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
[TBL] [Abstract][Full Text] [Related]
6. Insulin sensitivity in cystic fibrosis.
Moran A; Pyzdrowski KL; Weinreb J; Kahn BB; Smith SA; Adams KS; Seaquist ER
Diabetes; 1994 Aug; 43(8):1020-6. PubMed ID: 8039595
[TBL] [Abstract][Full Text] [Related]
7. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
[TBL] [Abstract][Full Text] [Related]
8. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity.
Baron AD; Zhu JS; Zhu JH; Weldon H; Maianu L; Garvey WT
J Clin Invest; 1995 Dec; 96(6):2792-801. PubMed ID: 8675649
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
[TBL] [Abstract][Full Text] [Related]
10. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance.
Hughes VA; Fiatarone MA; Fielding RA; Kahn BB; Ferrara CM; Shepherd P; Fisher EC; Wolfe RR; Elahi D; Evans WJ
Am J Physiol; 1993 Jun; 264(6 Pt 1):E855-62. PubMed ID: 8333511
[TBL] [Abstract][Full Text] [Related]
11. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: effects on blood flow and differential expression of GLUT 4 in skeletal muscles.
Hardin DS; Azzarelli B; Edwards J; Wigglesworth J; Maianu L; Brechtel G; Johnson A; Baron A; Garvey WT
J Clin Endocrinol Metab; 1995 Aug; 80(8):2437-46. PubMed ID: 7629239
[TBL] [Abstract][Full Text] [Related]
13. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis.
Austin A; Kalhan SC; Orenstein D; Nixon P; Arslanian S
J Clin Endocrinol Metab; 1994 Jul; 79(1):80-5. PubMed ID: 8027259
[TBL] [Abstract][Full Text] [Related]
14. Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle.
Magnan C; Gilbert M; Kahn BB
Lipids; 1996 Nov; 31(11):1141-9. PubMed ID: 8934446
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of tumor necrosis factor-alpha, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance.
Blüher M; Kratzsch J; Paschke R
Diabetes Care; 2001 Feb; 24(2):328-34. PubMed ID: 11213887
[TBL] [Abstract][Full Text] [Related]
16. Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance.
Moran A; Basu R; Milla C; Jensen MD
Metabolism; 2004 Nov; 53(11):1467-72. PubMed ID: 15536603
[TBL] [Abstract][Full Text] [Related]
17. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
[TBL] [Abstract][Full Text] [Related]
18. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats.
Cefalu WT; Wang ZQ; Zhang XH; Baldor LC; Russell JC
J Nutr; 2002 Jun; 132(6):1107-14. PubMed ID: 12042418
[TBL] [Abstract][Full Text] [Related]
19. Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism.
Moors CC; van der Zijl NJ; Diamant M; Blaak EE; Goossens GH
Int J Obes (Lond); 2012 May; 36(5):709-17. PubMed ID: 21712806
[TBL] [Abstract][Full Text] [Related]
20. Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients.
Battezzati A; Mari A; Zazzeron L; Alicandro G; Claut L; Battezzati PM; Colombo C
Eur J Endocrinol; 2011 Jul; 165(1):69-76. PubMed ID: 21502328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
